MYOT

myotilin, the group of I-set domain containing

Basic information

Region (hg38): 5:137867858-137887851

Previous symbols: [ "TTID", "LGMD1A", "LGMD1" ]

Links

ENSG00000120729NCBI:9499OMIM:604103HGNC:12399Uniprot:Q9UBF9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • spheroid body myopathy (Supportive), mode of inheritance: AD
  • myofibrillar myopathy 3 (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Myopathy, myofibrillar, 3ADCardiovascularIndividuals typically present with slowly progressive weakness, and a significant proportion of individuals demonstrate cardiomyopathy, such that surveillance for arrhythmia or conduction defects may allow early treatment (eg, pacemaker, ICD, as well as medical treatment with ACE inhibitors and/or beta-blockers); Cardiac transplantation may be necessary in individuals with severe forms of cardiomyopathyCardiovascular; Musculoskeletal; Neurologic571956; 3275904; 9270668; 10958653; 12428213; 15111675; 16380616; 20301672; 21336781; 21676617

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MYOT gene.

  • not provided (2 variants)
  • Myofibrillar myopathy 3 (2 variants)
  • Myofibrillar myopathy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYOT gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
65
clinvar
1
clinvar
70
missense
2
clinvar
3
clinvar
180
clinvar
9
clinvar
194
nonsense
1
clinvar
5
clinvar
6
start loss
1
clinvar
1
frameshift
9
clinvar
1
clinvar
10
inframe indel
4
clinvar
4
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
8
7
1
16
non coding
10
clinvar
36
clinvar
20
clinvar
66
Total 2 4 215 111 21

Variants in MYOT

This is a list of pathogenic ClinVar variants found in the MYOT region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-137867879-C-G Myofibrillar myopathy 3 Uncertain significance (Feb 02, 2018)903840
5-137867914-A-G Myofibrillar myopathy 3 • Limb-Girdle Muscular Dystrophy, Dominant Benign/Likely benign (May 29, 2020)351018
5-137867932-C-A Limb-Girdle Muscular Dystrophy, Dominant • Myofibrillar Myopathy, Dominant • Myofibrillar myopathy 3 Benign/Likely benign (Jan 13, 2018)351019
5-137870126-TA-T Benign (Aug 10, 2019)1259097
5-137870126-T-TA Likely benign (Jan 28, 2020)1196566
5-137870141-A-G Benign (Oct 26, 2019)1248942
5-137870267-T-A Benign (Jul 15, 2018)1178361
5-137870288-GACACAC-G Benign (Nov 07, 2019)1295552
5-137870288-G-GAC Benign (Aug 06, 2019)1261559
5-137870288-G-GACAC Benign (Aug 06, 2019)1225913
5-137870288-G-GACACAC Benign (Aug 18, 2019)1268891
5-137870288-G-GACACACAC Benign (Aug 10, 2019)1266810
5-137870288-G-GACACACACAC Likely benign (Dec 07, 2019)1212515
5-137870487-C-T Myofibrillar Myopathy, Dominant • Limb-Girdle Muscular Dystrophy, Dominant • Myofibrillar myopathy 3 Uncertain significance (Jun 14, 2016)351020
5-137870561-AG-A Limb-Girdle Muscular Dystrophy, Dominant • Myofibrillar Myopathy, Dominant • Myofibrillar myopathy 3 Uncertain significance (Jun 14, 2016)351021
5-137870652-A-T Myofibrillar myopathy 3 Uncertain significance (Feb 01, 2018)580989
5-137870663-C-T Myofibrillar myopathy 3 Likely benign (Sep 13, 2023)2918818
5-137870664-G-A Myofibrillar myopathy 3 Uncertain significance (Jun 25, 2023)3011844
5-137870667-C-G Myofibrillar myopathy 3 Uncertain significance (Nov 12, 2023)2732133
5-137870667-C-T Myofibrillar myopathy 3 Uncertain significance (Oct 13, 2023)2059499
5-137870668-G-A Myofibrillar myopathy 3 Conflicting classifications of pathogenicity (Nov 22, 2022)30407
5-137870683-T-C Myofibrillar myopathy 3 Uncertain significance (Jul 03, 2023)2734790
5-137870685-C-G Uncertain significance (Aug 09, 2016)290189
5-137870699-A-C Myofibrillar myopathy 3 Likely benign (Jul 06, 2022)1658019
5-137870700-T-A Myofibrillar myopathy 3 Uncertain significance (Feb 18, 2022)2094657

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MYOTprotein_codingprotein_codingENST00000239926 920061
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.37e-80.9321256890591257480.000235
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5532412660.9050.00001383249
Missense in Polyphen8598.1850.865711179
Synonymous-0.95810492.31.130.00000447959
Loss of Function1.861626.30.6090.00000135310

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007940.000793
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.00004620.0000462
European (Non-Finnish)0.0001860.000185
Middle Eastern0.0001630.000163
South Asian0.0005890.000588
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of a complex of multiple actin cross-linking proteins. Involved in the control of myofibril assembly and stability at the Z lines in muscle cells. {ECO:0000269|PubMed:12499399}.;
Disease
DISEASE: Myopathy, myofibrillar, 3 (MFM3) [MIM:609200]: A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM3 is characterized by progressive skeletal muscle weakness greater distally than proximally, tight heel cords, hyporeflexia, cardiomyopathy and peripheral neuropathy in some patients. Affected muscle exhibits disorganization and streaming of the Z-line, presence of large hyaline structures, excessive accumulation of myotilin and other ectopically expressed proteins and prominent congophilic deposits. {ECO:0000269|PubMed:15111675}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spheroid body myopathy (SBM) [MIM:182920]: Autosomal dominant form of myofibrillar myopathy (MFM), characterized by slowly progressing proximal muscle weakness and dysarthric nasal speech. There is no evidence of cardiomyopathy. Muscle biopsy shows spheroid bodies within the type I muscle fibers. {ECO:0000269|PubMed:16380616}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.227

Intolerance Scores

loftool
0.923
rvis_EVS
-0.31
rvis_percentile_EVS
32.06

Haploinsufficiency Scores

pHI
0.606
hipred
N
hipred_score
0.486
ghis
0.547

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.135

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Myot
Phenotype
normal phenotype;

Zebrafish Information Network

Gene name
myot
Affected structure
skeletal muscle
Phenotype tag
abnormal
Phenotype quality
refractivity

Gene ontology

Biological process
muscle contraction;homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;synapse organization
Cellular component
plasma membrane;actin cytoskeleton;Z disc;axon;sarcolemma;neuronal cell body
Molecular function
actin binding;protein binding;axon guidance receptor activity;structural constituent of muscle;alpha-actinin binding